Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cascade Acquisition CorpCASU · Entity 145010 | Chief Operating Officer & CFO | November 19, 2020 | November 20, 2020 |
| MACERICH COMAC · Entity 3712 | Director | June 01, 2026 | June 02, 2026 |
| Nuburu, Inc.BURU · Entity 7846 | Director | October 01, 2024 | October 04, 2024 |
| Playa Hotels & Resorts N.V.PLYA · Entity 78181 | Director | January 02, 2020 | January 06, 2020 |
| Ready Capital CorpRC · Entity 5999 | Director | February 22, 2024 | February 27, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cascade Acquisition Corp
Report date November 19, 2020 · Filed November 20, 2020
This filing explicitly reported no securities owned.
MACERICH CO
Report date June 01, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,898 |
Reported balance
After 2026-06-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 6,720 · Balance 91,898 F1: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award date. F2: Includes 2,922 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. |
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 4,732 |
Reported balance
Holding disclosure · report date 2026-06-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,732 |
Filing footnotes · ownership attribution and instrument terms
F1: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award date.
F2: Includes 2,922 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan.
Nuburu, Inc.
Report date October 01, 2024 · Filed October 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.45 · Expires 2034-10-01 | Direct | 13,889 |
Reported balance
After 2024-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-10-01 · Grant · Acquired 13,889 · Balance 13,889 |
Playa Hotels & Resorts N.V.
Report date January 02, 2020 · Filed January 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 74,524 |
Reported balance
After 2020-01-02 transaction · row 1
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 9,470 · Balance 74,524 F1: Represents restricted Ordinary Shares granted to the reporting person pursuant to the issuer's 2017 Omnibus Incentive Plan. The shares will vest on the first anniversary of the grant date, subject to the reporting person's continued service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted Ordinary Shares granted to the reporting person pursuant to the issuer's 2017 Omnibus Incentive Plan. The shares will vest on the first anniversary of the grant date, subject to the reporting person's continued service as a director.
Ready Capital Corp
Report date February 22, 2024 · Filed February 27, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 116,788 |
Reported balance
After 2024-02-22 transaction · row 1
1 source rowRow 1 · 2024-02-22 · Grant · Acquired 12,693 · Balance 116,788 F1: On February 22, 2024, the reporting person was awarded 12,693 shares of restricted Common Stock under the Ready Capital Corporation 2023 Equity Incentive Plan. The shares will vest in equal installments of one-quarter on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 22, 2024, the reporting person was awarded 12,693 shares of restricted Common Stock under the Ready Capital Corporation 2023 Equity Incentive Plan. The shares will vest in equal installments of one-quarter on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.
Past disclosures · reporting ended (4)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Broadmark Realty Capital Inc.
Report date May 31, 2023 · Filed June 02, 2023
Section 16 reporting ended · disclosed 2023-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-05-31 transaction · row 1
1 source rowRow 1 · 2023-05-31 · Disposition to issuer · Disposed 206,532 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of February 26, 2023 (the "Agreement"), by and among Ready Capital Corporation, a Maryland corporation ("Parent"), RCC Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ("Merger Sub"), and the Issuer, effective May 31, 2023 (the "Effective Time"), the Issuer was merged with and into Merger Sub with Merger Sub continuing as the surviving company and a subsidiary of Parent. F2: Pursuant to the Agreement, at the Effective Time, each one share of the Issuer's common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was converted into the right to 0.47233 shares (the "Exchange Ratio") of Parent's common stock ("Parent Common Stock"), with fractional shares paid out in cash. F4: Pursuant to the Agreement, at the Effective Time, each Issuer RSU outstanding, whether vested or unvested, was assumed by Parent and converted into an award of RSUs with respect to a number of shares of Parent Common Stock equal to the product of (i) the total number of shares of Common Stock subject to such RSUs as of immediately prior to the Effective Time and (ii) the Exchange Ratio (rounded to the nearest whole share), on the same terms and conditions as were applicable to such RSUs as of immediately prior to the Effective Time. F3: Includes 13,050 restricted stock units ("RSUs") unvested immediately prior to the Effective Time. Each RSU represented a contingent right to receive one share of Common Stock upon vesting. |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2024-11-14 | Direct | 0 |
Reported balance
After 2023-05-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-05-31 · Disposition to issuer · Disposed 259 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of February 26, 2023 (the "Agreement"), by and among Ready Capital Corporation, a Maryland corporation ("Parent"), RCC Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ("Merger Sub"), and the Issuer, effective May 31, 2023 (the "Effective Time"), the Issuer was merged with and into Merger Sub with Merger Sub continuing as the surviving company and a subsidiary of Parent. F5: Pursuant to the Agreement, following the Effective Time, each Issuer warrant representing the right to purchase shares of Common Stock ("Warrants") remained outstanding and entitles the Reporting Person to receive, upon the exercise of such Warrants, the number of shares of Parent Common Stock equal to the product of (i) the number of shares of Common Stock subject to such Warrants immediately prior to the Effective Time and (ii) the Exchange Ratio, on the same terms and conditions as were applicable to such Warrants as of immediately prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of February 26, 2023 (the "Agreement"), by and among Ready Capital Corporation, a Maryland corporation ("Parent"), RCC Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ("Merger Sub"), and the Issuer, effective May 31, 2023 (the "Effective Time"), the Issuer was merged with and into Merger Sub with Merger Sub continuing as the surviving company and a subsidiary of Parent.
F2: Pursuant to the Agreement, at the Effective Time, each one share of the Issuer's common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was converted into the right to 0.47233 shares (the "Exchange Ratio") of Parent's common stock ("Parent Common Stock"), with fractional shares paid out in cash.
F3: Includes 13,050 restricted stock units ("RSUs") unvested immediately prior to the Effective Time. Each RSU represented a contingent right to receive one share of Common Stock upon vesting.
F4: Pursuant to the Agreement, at the Effective Time, each Issuer RSU outstanding, whether vested or unvested, was assumed by Parent and converted into an award of RSUs with respect to a number of shares of Parent Common Stock equal to the product of (i) the total number of shares of Common Stock subject to such RSUs as of immediately prior to the Effective Time and (ii) the Exchange Ratio (rounded to the nearest whole share), on the same terms and conditions as were applicable to such RSUs as of immediately prior to the Effective Time.
F5: Pursuant to the Agreement, following the Effective Time, each Issuer warrant representing the right to purchase shares of Common Stock ("Warrants") remained outstanding and entitles the Reporting Person to receive, upon the exercise of such Warrants, the number of shares of Parent Common Stock equal to the product of (i) the number of shares of Common Stock subject to such Warrants immediately prior to the Effective Time and (ii) the Exchange Ratio, on the same terms and conditions as were applicable to such Warrants as of immediately prior to the Effective Time.
Envoy Medical, Inc.
Report date September 29, 2023 · Filed October 04, 2023
Section 16 reporting ended · disclosed 2023-10-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 25,000 |
Reported balance
After 2023-09-29 transaction · row 1
1 source rowRow 1 · 2023-09-29 · Conversion · Acquired 25,000 · Balance 25,000 F1: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. |
| Class B Common Stock, par value $0.0001 per shareSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-09-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-09-29 · Conversion · Disposed 25,000 · Balance 0 F1: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu.
Nexvet Biopharma plc
Report date December 31, 2016 · Filed January 11, 2017
Section 16 reporting ended · disclosed 2017-01-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
Holding disclosure · report date 2016-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 F1: Daniel J. Hirsch ("Hirsch") previously filed Form 3s and Form 4s with respect to securities of the Issuer owned directly by Akubra Investors, LLC ("Akubra"), Bushranger Funding, LLC ("Bushranger"), Ute Holdings, LLC ("Ute" and, together with Akubra and Bushranger, the "Farallon SPVs"). F2: The members of Akubra are FCIP XR 2014, L.L.C. ("FCIP XR") and Noonday Special Situation Partners, L.P. ("NSSP") (each, a "Farallon Akubra Fund"). As the general partner of NSSP, NGP, L.L.C. (the "NSSP General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by NSSP as a Farallon Akubra Fund. The NSSP General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "'34 Act"), or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Akubra. F3: As the manager of the NSSP General Partner, Farallon Capital Management, L.L.C. (the "Management Company") may be deemed to be a beneficial owner of the Issuer's securities held by NSSP as a Farallon Akubra Fund. The Management Company disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Akubra. F4: The members of Bushranger are FCP XR 2014, L.L.C. ("FCP XR"), Farallon Capital Institutional Partners III, L.P. ("FCIP III"), and Farallon Capital AA Investors, L.P. ("FCAAI") (collectively, the "Farallon Bushranger Funds"). As the general partner of FCAAI, Farallon AA GP, L.L.C. (the "FCAAI General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FCAAI as a Farallon Bushranger Fund. The FCAAI General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Bushranger. F5: The members of Ute are FCOI II SS 2014, Ltd. ("FCOI II SS"), Farallon Capital Institutional Partners II, L.P. ("FCIP II"), and Farallon Special Situation Partners VI, L.P. ("FSSP VI") (collectively, the "Farallon Ute Funds"). As the general partner of FSSP VI, Farallon Partners GP VI, L.L.C. (the "FSSP VI General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FSSP VI as a Farallon Ute Fund. The FSSP VI General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Ute. F6: As the general partner of each of (a) the sole member of FCIP XR, (b) the sole member of FCP XR, (c) FCIP III, (d) the sole member of FCOI II SS and (e) FCIP II, Farallon Partners, L.L.C. (the "Farallon General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FCIP XR as a Farallon Akubra Fund, FCP XR and FCIP III as Farallon Bushranger Funds, and FCOI II SS and FCIP II as Farallon Ute Funds. The Farallon General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, the Farallon SPVs. F7: Hirsch, as a managing member of both the Farallon General Partner and the Management Company, and as a manager of both the FCAAI General Partner and the FSSP VI General Partner, in each case with the power to exercise investment discretion, may have been deemed to be a beneficial owner of the Issuer's securities held by the Farallon SPVs. Effective as of December 31, 2016, in connection with his resignation as a managing member of both the Farallon General Partner and the Management Company, and as a manager of both the FCAAI General Partner and the FSSP VI General Partner, Hirsch may no longer be deemed a beneficial owner of any of the Issuer's securities deemed beneficially owned by each of the Farallon General Partner, the Management Company, the FCAAI General Partner and the FSSP VI General Partner. F8: Hirsch and the other individuals identified in the prior Form 3s and Form 4s filed by the foregoing disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein or therein for purposes of Section 16 of the '34 Act, or otherwise, except to the extent of his or her pecuniary interest, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Daniel J. Hirsch ("Hirsch") previously filed Form 3s and Form 4s with respect to securities of the Issuer owned directly by Akubra Investors, LLC ("Akubra"), Bushranger Funding, LLC ("Bushranger"), Ute Holdings, LLC ("Ute" and, together with Akubra and Bushranger, the "Farallon SPVs").
F2: The members of Akubra are FCIP XR 2014, L.L.C. ("FCIP XR") and Noonday Special Situation Partners, L.P. ("NSSP") (each, a "Farallon Akubra Fund"). As the general partner of NSSP, NGP, L.L.C. (the "NSSP General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by NSSP as a Farallon Akubra Fund. The NSSP General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "'34 Act"), or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Akubra.
F3: As the manager of the NSSP General Partner, Farallon Capital Management, L.L.C. (the "Management Company") may be deemed to be a beneficial owner of the Issuer's securities held by NSSP as a Farallon Akubra Fund. The Management Company disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Akubra.
F4: The members of Bushranger are FCP XR 2014, L.L.C. ("FCP XR"), Farallon Capital Institutional Partners III, L.P. ("FCIP III"), and Farallon Capital AA Investors, L.P. ("FCAAI") (collectively, the "Farallon Bushranger Funds"). As the general partner of FCAAI, Farallon AA GP, L.L.C. (the "FCAAI General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FCAAI as a Farallon Bushranger Fund. The FCAAI General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Bushranger.
F5: The members of Ute are FCOI II SS 2014, Ltd. ("FCOI II SS"), Farallon Capital Institutional Partners II, L.P. ("FCIP II"), and Farallon Special Situation Partners VI, L.P. ("FSSP VI") (collectively, the "Farallon Ute Funds"). As the general partner of FSSP VI, Farallon Partners GP VI, L.L.C. (the "FSSP VI General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FSSP VI as a Farallon Ute Fund. The FSSP VI General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Ute.
F6: As the general partner of each of (a) the sole member of FCIP XR, (b) the sole member of FCP XR, (c) FCIP III, (d) the sole member of FCOI II SS and (e) FCIP II, Farallon Partners, L.L.C. (the "Farallon General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FCIP XR as a Farallon Akubra Fund, FCP XR and FCIP III as Farallon Bushranger Funds, and FCOI II SS and FCIP II as Farallon Ute Funds. The Farallon General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, the Farallon SPVs.
F7: Hirsch, as a managing member of both the Farallon General Partner and the Management Company, and as a manager of both the FCAAI General Partner and the FSSP VI General Partner, in each case with the power to exercise investment discretion, may have been deemed to be a beneficial owner of the Issuer's securities held by the Farallon SPVs. Effective as of December 31, 2016, in connection with his resignation as a managing member of both the Farallon General Partner and the Management Company, and as a manager of both the FCAAI General Partner and the FSSP VI General Partner, Hirsch may no longer be deemed a beneficial owner of any of the Issuer's securities deemed beneficially owned by each of the Farallon General Partner, the Management Company, the FCAAI General Partner and the FSSP VI General Partner.
F8: Hirsch and the other individuals identified in the prior Form 3s and Form 4s filed by the foregoing disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein or therein for purposes of Section 16 of the '34 Act, or otherwise, except to the extent of his or her pecuniary interest, if any.
TOWN SPORTS INTERNATIONAL HOLDINGS INC
Report date December 31, 2016 · Filed January 11, 2017
Section 16 reporting ended · disclosed 2017-01-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
Holding disclosure · report date 2016-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 F1: Daniel J. Hirsch ("Hirsch") previously filed Form 3s and Form 4s with respect to securities of the Issuer owned directly by Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P. and Farallon Capital Offshore Investors II, L.P. (collectively, the "Farallon Funds"). F2: As a managing member of Farallon Partners, L.L.C. ("FPLLC"), the general partner of each of the Farallon Funds, Hirsch may have been deemed a beneficial owner of the Issuer's securities deemed beneficially owned by FPLLC. Effective as of December 31, 2016, in connection with his resignation as managing member of FPLLC, Hirsch may no longer be deemed a beneficial owner of any of the Issuer's securities deemed beneficially owned by FPLLC. F3: Hirsch and the other individuals identified in the prior Form 3s and Form 4s filed by the foregoing disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein or therein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "'34 Act"), or otherwise, except to the extent of his or her pecuniary interest, if any. FPLLC disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein or in such prior Form 3s and Form 4s for purposes of Section 16 of the '34 Act or otherwise, except as to securities representing FPLLC's pro rata interest in, and interest in the profits of, the Farallon Funds. |
Filing footnotes · ownership attribution and instrument terms
F1: Daniel J. Hirsch ("Hirsch") previously filed Form 3s and Form 4s with respect to securities of the Issuer owned directly by Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P. and Farallon Capital Offshore Investors II, L.P. (collectively, the "Farallon Funds").
F2: As a managing member of Farallon Partners, L.L.C. ("FPLLC"), the general partner of each of the Farallon Funds, Hirsch may have been deemed a beneficial owner of the Issuer's securities deemed beneficially owned by FPLLC. Effective as of December 31, 2016, in connection with his resignation as managing member of FPLLC, Hirsch may no longer be deemed a beneficial owner of any of the Issuer's securities deemed beneficially owned by FPLLC.
F3: Hirsch and the other individuals identified in the prior Form 3s and Form 4s filed by the foregoing disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein or therein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "'34 Act"), or otherwise, except to the extent of his or her pecuniary interest, if any. FPLLC disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein or in such prior Form 3s and Form 4s for purposes of Section 16 of the '34 Act or otherwise, except as to securities representing FPLLC's pro rata interest in, and interest in the profits of, the Farallon Funds.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 2, 2026 20:23 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 6,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001453077-26-000002 · wk-form4_1780431819.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,898 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award date. F2 · balance_after: Includes 2,922 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:30 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 8,348 | $0.00 | $0.00 |
DisclosureSEC source: 0000912242-25-000060 · wk-form4_1749083440.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,256 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award date. F2 · balance_after: Includes 2,802 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. Read SEC document |
| October 01, 2024 Filed Oct 4, 2024 14:39 UTC | Nuburu, Inc. BURU · Entity 7846 | GrantStock Option (right to buy) · Derivative | 13,889 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0000950170-24-112754 · ownership.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,889 Underlying: Common Stock · 13,889 shares Expires 2034-10-01 Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:00 UTC | Nuburu, Inc. BURU · Entity 7846 | GrantStock Option (right to buy) · Derivative | 13,889 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0000950170-24-080650 · ownership.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,889 Underlying: Common Stock · 13,889 shares Expires 2034-07-01 Read SEC document |
| May 30, 2024 Filed Jun 4, 2024 00:18 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 9,103 | $0.00 | $0.00 |
DisclosureSEC source: 0000912242-24-000105 · wk-form4_1717460313.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,106 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award date. F2 · balance_after: Includes 3,088 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:30 UTC | Nuburu, Inc. BURU · Entity 7846 | GrantStock Option (right to buy) · Derivative | 20,833 | $0.00 Strike: $0.14 | $0.00 |
DisclosureSEC source: 0000950170-24-040237 · ownership.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,833 Underlying: Common Stock · 20,833 shares Expires 2034-04-01 Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 02:38 UTC | Ready Capital Corp RC · Entity 5999 | GrantCommon stock | 12,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027765 · tm246309-13_4seq1.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,788 F1 · shares: On February 22, 2024, the reporting person was awarded 12,693 shares of restricted Common Stock under the Ready Capital Corporation 2023 Equity Incentive Plan. The shares will vest in equal installments of one-quarter on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:55 UTC | Nuburu, Inc. BURU · Entity 7846 | GrantStock Option (right to buy) · Derivative | 41,667 | $0.00 Strike: $0.17 | $0.00 |
DisclosureSEC source: 0000950170-24-002020 · ownership.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,667 Underlying: Common Stock · 41,667 shares Expires 2034-01-02 Read SEC document |
| September 29, 2023 Filed Oct 4, 2023 01:46 UTC | Envoy Medical, Inc. COCH · Entity 7161 | ConversionClass B Common Stock, par value $0.0001 per share · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-018934 · form4.xml · derivative · entry 2 Hirsch Daniel J. · CIK 0001453077 · Director · CFO and Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock, par value $0.0001 per share · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. F1 · kind: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. F1 · price: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. F1 · derivative.exercise_date: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. F1 · derivative.expiration_date: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. Read SEC document |
| September 29, 2023 Filed Oct 4, 2023 01:46 UTC | Envoy Medical, Inc. COCH · Entity 7161 | ConversionClass A Common Stock, par value $0.0001 per share | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-018934 · form4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director · CFO and Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. F1 · price: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu. Read SEC document |
| August 31, 2023 Filed Sep 1, 2023 21:06 UTC | Nuburu, Inc. BURU · Entity 7846 | GrantStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001209191-23-047982 · doc4.xml · derivative · entry 2 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 18,750 shares Expires 2033-08-31 F2 · derivative.exercise_date: The shares subject to this stock option are subject to service-based vesting requirements. 1/12th of the shares subject to the option shall vest and become exercisable on the first day of each month following January 31, 2023 beginning on February 1, 2023 such that 100% of the shares subject to this stock option will be vested on January 1, 2024, subject to the Report Person remaining a service provider through each such vesting date. Read SEC document |
| August 31, 2023 Filed Sep 1, 2023 21:06 UTC | Nuburu, Inc. BURU · Entity 7846 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001209191-23-047982 · doc4.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-08-31 F1 · derivative.exercise_date: The shares subject to this stock option are subject to service-based vesting requirements. 1/12th of the shares subject to the option shall vest and become exercisable on the first day of each month following June 16, 2023 beginning on July 1, 2023 such that 100% of the shares subject to this stock option will be vested on June 1, 2024, subject to the Report Person remaining a service provider through each such vesting date. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 01:34 UTC | Ready Capital Corp RC · Entity 5999 | GrantCommon stock | 6,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-068241 · tm2317644-6_4seq1.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,095 F1 · shares: On June 1, 2023, the reporting person was awarded 6,545 Restricted Stock Units ("RSUs") under the 2013 Ready Capital Corporation Equity Incentive Plan, which represent the right to receive one share of Common Stock of the Issuer for each RSU at vesting or, at the election of the reporting person, a deferred settlement date. 935 RSUs will vest on June 30, 2023, 2,805 RSUs will vest on September 30, 2023, and the remaining 2,805 RSUs will vest on December 31, 2023. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 22:32 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 14,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033989 · doc4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,915 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award. F2 · balance_after: Includes 2,291 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:15 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | Disposition to issuerWarrants (Right to Buy) · Derivative | 259 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001140361-23-028041 · form4.xml · derivative · entry 2 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 259 shares Expires 2024-11-14 F1 · kind: Pursuant to the Agreement and Plan of Merger, dated as of February 26, 2023 (the "Agreement"), by and among Ready Capital Corporation, a Maryland corporation ("Parent"), RCC Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ("Merger Sub"), and the Issuer, effective May 31, 2023 (the "Effective Time"), the Issuer was merged with and into Merger Sub with Merger Sub continuing as the surviving company and a subsidiary of Parent. F5 · kind: Pursuant to the Agreement, following the Effective Time, each Issuer warrant representing the right to purchase shares of Common Stock ("Warrants") remained outstanding and entitles the Reporting Person to receive, upon the exercise of such Warrants, the number of shares of Parent Common Stock equal to the product of (i) the number of shares of Common Stock subject to such Warrants immediately prior to the Effective Time and (ii) the Exchange Ratio, on the same terms and conditions as were applicable to such Warrants as of immediately prior to the Effective Time. F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of February 26, 2023 (the "Agreement"), by and among Ready Capital Corporation, a Maryland corporation ("Parent"), RCC Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ("Merger Sub"), and the Issuer, effective May 31, 2023 (the "Effective Time"), the Issuer was merged with and into Merger Sub with Merger Sub continuing as the surviving company and a subsidiary of Parent. F5 · price: Pursuant to the Agreement, following the Effective Time, each Issuer warrant representing the right to purchase shares of Common Stock ("Warrants") remained outstanding and entitles the Reporting Person to receive, upon the exercise of such Warrants, the number of shares of Parent Common Stock equal to the product of (i) the number of shares of Common Stock subject to such Warrants immediately prior to the Effective Time and (ii) the Exchange Ratio, on the same terms and conditions as were applicable to such Warrants as of immediately prior to the Effective Time. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:15 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | Disposition to issuerCommon Stock | 206,532 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-028041 · form4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger, dated as of February 26, 2023 (the "Agreement"), by and among Ready Capital Corporation, a Maryland corporation ("Parent"), RCC Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ("Merger Sub"), and the Issuer, effective May 31, 2023 (the "Effective Time"), the Issuer was merged with and into Merger Sub with Merger Sub continuing as the surviving company and a subsidiary of Parent. F2 · kind: Pursuant to the Agreement, at the Effective Time, each one share of the Issuer's common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was converted into the right to 0.47233 shares (the "Exchange Ratio") of Parent's common stock ("Parent Common Stock"), with fractional shares paid out in cash. F4 · kind: Pursuant to the Agreement, at the Effective Time, each Issuer RSU outstanding, whether vested or unvested, was assumed by Parent and converted into an award of RSUs with respect to a number of shares of Parent Common Stock equal to the product of (i) the total number of shares of Common Stock subject to such RSUs as of immediately prior to the Effective Time and (ii) the Exchange Ratio (rounded to the nearest whole share), on the same terms and conditions as were applicable to such RSUs as of immediately prior to the Effective Time. F3 · shares: Includes 13,050 restricted stock units ("RSUs") unvested immediately prior to the Effective Time. Each RSU represented a contingent right to receive one share of Common Stock upon vesting. F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of February 26, 2023 (the "Agreement"), by and among Ready Capital Corporation, a Maryland corporation ("Parent"), RCC Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent ("Merger Sub"), and the Issuer, effective May 31, 2023 (the "Effective Time"), the Issuer was merged with and into Merger Sub with Merger Sub continuing as the surviving company and a subsidiary of Parent. F2 · price: Pursuant to the Agreement, at the Effective Time, each one share of the Issuer's common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was converted into the right to 0.47233 shares (the "Exchange Ratio") of Parent's common stock ("Parent Common Stock"), with fractional shares paid out in cash. F4 · price: Pursuant to the Agreement, at the Effective Time, each Issuer RSU outstanding, whether vested or unvested, was assumed by Parent and converted into an award of RSUs with respect to a number of shares of Parent Common Stock equal to the product of (i) the total number of shares of Common Stock subject to such RSUs as of immediately prior to the Effective Time and (ii) the Exchange Ratio (rounded to the nearest whole share), on the same terms and conditions as were applicable to such RSUs as of immediately prior to the Effective Time. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 20:33 UTC | Nuburu, Inc. BURU · Entity 7846 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024991 · doc4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 F1 · shares: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. A total of one-eighth (1/8th) of the shares subject to this grant become vested on each Quarterly Vesting Date following the Vesting Commencement Date, subject to the Reporting Person remaining a service provider through each such vesting date. "Vesting Commencement Date" shall mean January 31, 2023. "Quarterly Vesting Date" shall mean each of January 31, April 30, July 31, and October 31. F2 · balance_after: Includes 25,000 shares granted as RSUs. As of the transaction date, zero RSUs have vested. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 21:03 UTC | Envoy Medical, Inc. ANZU · Entity 7161 | OtherClass B Common Stock, par value $0.0001 per share · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-020353 · form4.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director · CFO and Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock, par value $0.0001 per share · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: The shares of Class B common stock, par value $0.0001 per share (the "Class B Founder Shares") of Anzu Special Acquisition Corp I (the "Issuer") have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252861). F2 · kind: On October 1, 2022, Anzu SPAC GP I LLC assigned 25,000 Class B Founder Shares to the reporting person for an aggregate consideration of $5,250. F2 · price: On October 1, 2022, Anzu SPAC GP I LLC assigned 25,000 Class B Founder Shares to the reporting person for an aggregate consideration of $5,250. F1 · derivative.exercise_date: The shares of Class B common stock, par value $0.0001 per share (the "Class B Founder Shares") of Anzu Special Acquisition Corp I (the "Issuer") have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252861). F1 · derivative.expiration_date: The shares of Class B common stock, par value $0.0001 per share (the "Class B Founder Shares") of Anzu Special Acquisition Corp I (the "Issuer") have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252861). F1 · derivative.underlying_shares: The shares of Class B common stock, par value $0.0001 per share (the "Class B Founder Shares") of Anzu Special Acquisition Corp I (the "Issuer") have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252861). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:49 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | GrantCommon Stock | 13,050 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-22-000157 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,532 F1 · shares: Represents a grant of 13,050 restricted stock units ("RSUs") that will vest on the earlier to occur of (1) the one year anniversary of the date of the grant and (2) the election of directors at the first annual meeting of the Issuer's stockholders occurring after the date of the grant, with vesting accelerated in the event of death or disability or termination of service in connection with or within twenty-four (24) months following a change in control. Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 23:22 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 11,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033307 · doc4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,620 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award. F2 · balance_after: Includes 1,003 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:47 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | GrantCommon Stock | 8,227 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000343 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,482 F1 · shares: Represents a grant of 8,227 restricted stock units ("RSUs") that will vest on the earlier to occur of (1) the one year anniversary of the date of the grant and (2) the election of directors at the first annual meeting of the Issuer's stockholders occurring after the date of the grant, with vesting accelerated in the event of death or disability or termination of service in connection with or within twenty-four (24) months following a change in control. Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 23:25 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 8,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037432 · doc4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,096 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award. F2 · balance_after: Includes 901 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. Read SEC document |
| January 01, 2021 Filed Jan 6, 2021 00:43 UTC | MACERICH CO MAC · Entity 3712 | GrantPhantom Stock Units · Derivative | 4,435.11 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-001654 · doc4.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,171.9 Underlying: Common Stock · 4,435.11 shares Expires not disclosed F1 · derivative.exercise_price: Convertible on a 1 for 1 basis. F2 · derivative.exercise_date: The shares attributable to the phantom stock units generally first become distributable upon the January 1 following the date of termination of service pursuant to an earlier election in accordance with the Plan terms. F2 · derivative.expiration_date: The shares attributable to the phantom stock units generally first become distributable upon the January 1 following the date of termination of service pursuant to an earlier election in accordance with the Plan terms. F3 · balance_after: Includes 900.47 previously unreported phantom stock units accrued under the dividend reinvestment feature of the Plan. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 22:54 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 14,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038310 · doc4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,809 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award. F2 · balance_after: Includes 846 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 20:36 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | GrantCommon Stock | 9,337 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000288 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,950 F1 · shares: Represents a grant of 9,337 restricted stock units ("RSUs") that will vest on the earlier to occur of (1) the one year anniversary of the date of the grant and (2) the election of directors at the first annual meeting of the Issuer's stockholders occurring after the date of the grant, with vesting accelerated in the event of death or disability or termination of service in connection with a change in control. Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. F2 · balance_after: Mr. Hirsch served as a consultant to Trinity Real Estate Investments LLC ("Trinity Investments") from January 2019 until November 2019 pursuant to a consulting agreement. Mr. Hirsch's consulting agreement provides for a success fee payable by Trinity Investments to Mr. Hirsch in connection with the completion of the Issuer's business combination on November 14, 2019, pursuant to which Mr. Hirsch will receive 137,305 shares of the Issuer's common stock (the "Common Stock") and 259 warrants to acquire one share of Common Stock (the "Warrants") issued by the Issuer held by HN Investors LLC and expected to be transferred to Trinity Investments following the expiration of the lock-up agreement to which HN Investors LLC is a party. F3 · balance_after: These shares of Common Stock and the Warrants are expected to represent, in the aggregate, a less than 1% beneficial ownership interest by Mr. Hirsch in the Issuer. Instead of transferring these securities to Mr. Hirsch, Trinity Investments may, at its election, pay the success fee in cash in an amount equal to the value of these securities. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:24 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | PurchaseCommon Stock | 4,300 | $5.92 | $25,456.00 |
DisclosureSEC source: 0000950138-20-000187 · edgar.xml · nonDerivative · entry 4 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,613 F1 · balance_after: Mr. Hirsch served as a consultant to Trinity Real Estate Investments LLC ("Trinity Investments") from January 2019 until November 2019 pursuant to a consulting agreement. Mr. Hirsch's consulting agreement provides for a success fee payable by Trinity Investments to Mr. Hirsch in connection with the completion of the Issuer's business combination on November 14, 2019, pursuant to which Mr. Hirsch will receive 137,305 shares of the Issuer's common stock (the "Common Stock") and 259 warrants (the "Warrants") issued by the Issuer held by HN Investors LLC and expected to be transferred to Trinity Investments following the expiration of the lock-up agreement to which HN Investors LLC is a party. F2 · balance_after: These shares of Common Stock and the Warrants are expected to represent, in the aggregate, a less than 1% beneficial ownership interest by Mr. Hirsch in the Issuer. Instead of transferring these securities to Mr. Hirsch, Trinity Investments may, at its election, pay the success fee in cash in an amount equal to the value of these securities. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:24 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | PurchaseCommon Stock | 3,200 | $5.93 | $18,976.00 |
DisclosureSEC source: 0000950138-20-000187 · edgar.xml · nonDerivative · entry 3 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,313 F1 · balance_after: Mr. Hirsch served as a consultant to Trinity Real Estate Investments LLC ("Trinity Investments") from January 2019 until November 2019 pursuant to a consulting agreement. Mr. Hirsch's consulting agreement provides for a success fee payable by Trinity Investments to Mr. Hirsch in connection with the completion of the Issuer's business combination on November 14, 2019, pursuant to which Mr. Hirsch will receive 137,305 shares of the Issuer's common stock (the "Common Stock") and 259 warrants (the "Warrants") issued by the Issuer held by HN Investors LLC and expected to be transferred to Trinity Investments following the expiration of the lock-up agreement to which HN Investors LLC is a party. F2 · balance_after: These shares of Common Stock and the Warrants are expected to represent, in the aggregate, a less than 1% beneficial ownership interest by Mr. Hirsch in the Issuer. Instead of transferring these securities to Mr. Hirsch, Trinity Investments may, at its election, pay the success fee in cash in an amount equal to the value of these securities. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:24 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | PurchaseCommon Stock | 178 | $5.93 | $1,055.52 |
DisclosureSEC source: 0000950138-20-000187 · edgar.xml · nonDerivative · entry 2 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,113 F1 · balance_after: Mr. Hirsch served as a consultant to Trinity Real Estate Investments LLC ("Trinity Investments") from January 2019 until November 2019 pursuant to a consulting agreement. Mr. Hirsch's consulting agreement provides for a success fee payable by Trinity Investments to Mr. Hirsch in connection with the completion of the Issuer's business combination on November 14, 2019, pursuant to which Mr. Hirsch will receive 137,305 shares of the Issuer's common stock (the "Common Stock") and 259 warrants (the "Warrants") issued by the Issuer held by HN Investors LLC and expected to be transferred to Trinity Investments following the expiration of the lock-up agreement to which HN Investors LLC is a party. F2 · balance_after: These shares of Common Stock and the Warrants are expected to represent, in the aggregate, a less than 1% beneficial ownership interest by Mr. Hirsch in the Issuer. Instead of transferring these securities to Mr. Hirsch, Trinity Investments may, at its election, pay the success fee in cash in an amount equal to the value of these securities. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:24 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | PurchaseCommon Stock | 2,322 | $5.80 | $13,467.60 |
DisclosureSEC source: 0000950138-20-000187 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,935 F1 · balance_after: Mr. Hirsch served as a consultant to Trinity Real Estate Investments LLC ("Trinity Investments") from January 2019 until November 2019 pursuant to a consulting agreement. Mr. Hirsch's consulting agreement provides for a success fee payable by Trinity Investments to Mr. Hirsch in connection with the completion of the Issuer's business combination on November 14, 2019, pursuant to which Mr. Hirsch will receive 137,305 shares of the Issuer's common stock (the "Common Stock") and 259 warrants (the "Warrants") issued by the Issuer held by HN Investors LLC and expected to be transferred to Trinity Investments following the expiration of the lock-up agreement to which HN Investors LLC is a party. F2 · balance_after: These shares of Common Stock and the Warrants are expected to represent, in the aggregate, a less than 1% beneficial ownership interest by Mr. Hirsch in the Issuer. Instead of transferring these securities to Mr. Hirsch, Trinity Investments may, at its election, pay the success fee in cash in an amount equal to the value of these securities. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 20:26 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | PurchaseCommon Stock | 5,000 | $6.53 | $32,650.00 |
DisclosureSEC source: 0000950138-20-000181 · edgar.xml · nonDerivative · entry 2 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,613 F1 · balance_after: Mr. Hirsch served as a consultant to Trinity Real Estate Investments LLC ("Trinity Investments") from January 2019 until November 2019 pursuant to a consulting agreement. Mr. Hirsch's consulting agreement provides for a success fee payable by Trinity Investments to Mr. Hirsch in connection with the completion of the Issuer's business combination on November 14, 2019, pursuant to which Mr. Hirsch will receive 137,305 shares of the Issuer's common stock (the "Common Stock") and 259 warrants (the "Warrants") issued by the Issuer held by HN Investors LLC and expected to be transferred to Trinity Investments following the expiration of the lock-up agreement to which HN Investors LLC is a party. F2 · balance_after: These shares of Common Stock and the Warrants are expected to represent, in the aggregate, a less than 1% beneficial ownership interest by Mr. Hirsch in the Issuer. Instead of transferring these securities to Mr. Hirsch, Trinity Investments may, at its election, pay the success fee in cash in an amount equal to the value of these securities. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 20:26 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | PurchaseCommon Stock | 15,000 | $6.95 | $104,250.00 |
DisclosureSEC source: 0000950138-20-000181 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,613 F1 · balance_after: Mr. Hirsch served as a consultant to Trinity Real Estate Investments LLC ("Trinity Investments") from January 2019 until November 2019 pursuant to a consulting agreement. Mr. Hirsch's consulting agreement provides for a success fee payable by Trinity Investments to Mr. Hirsch in connection with the completion of the Issuer's business combination on November 14, 2019, pursuant to which Mr. Hirsch will receive 137,305 shares of the Issuer's common stock (the "Common Stock") and 259 warrants (the "Warrants") issued by the Issuer held by HN Investors LLC and expected to be transferred to Trinity Investments following the expiration of the lock-up agreement to which HN Investors LLC is a party. F2 · balance_after: These shares of Common Stock and the Warrants are expected to represent, in the aggregate, a less than 1% beneficial ownership interest by Mr. Hirsch in the Issuer. Instead of transferring these securities to Mr. Hirsch, Trinity Investments may, at its election, pay the success fee in cash in an amount equal to the value of these securities. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 22:05 UTC | Broadmark Realty Capital Inc. BRMK · Entity 112778 | GrantCommon Stock | 8,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-002410 · form4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,613 F1 · shares: Represents a grant to Mr. Hirsch of 8,613 restricted stock units ("RSUs") that vest in full on November 14, 2020. Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. F2 · balance_after: Mr. Hirsch served as a consultant to Trinity Real Estate Investments LLC ("Trinity Investments") from January 2019 until November 2019 pursuant to a consulting agreement. Mr. Hirsch's consulting agreement provides for a success fee payable by Trinity Investments to Mr. Hirsch in connection with the completion of the Issuer's business combination on November 14, 2019, pursuant to which Mr. Hirsch will receive 137,305 shares of the Issuer's common stock (the "Common Stock") and 259 warrants (the "Warrants") issued by the Issuer held by HN Investors LLC and expected to be transferred to Trinity Investments following the expiration of the lock-up agreement to which HN Investors LLC is a party. F3 · balance_after: These shares of Common Stock and the Warrants are expected to represent, in the aggregate, a less than 1% beneficial ownership interest by Mr. Hirsch in the Issuer. Instead of transferring these securities to Mr. Hirsch, Trinity Investments may, at its election, pay the success fee in cash in an amount equal to the value of these securities. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:51 UTC | Playa Hotels & Resorts N.V. PLYA · Entity 78181 | GrantOrdinary Shares | 9,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-20-000091 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,524 F1 · shares: Represents restricted Ordinary Shares granted to the reporting person pursuant to the issuer's 2017 Omnibus Incentive Plan. The shares will vest on the first anniversary of the grant date, subject to the reporting person's continued service as a director. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 22:56 UTC | MACERICH CO MAC · Entity 3712 | GrantPhantom Stock Units · Derivative | 3,588.97 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001337 · doc4.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,836.32 Underlying: Common Stock · 3,588.97 shares Expires not disclosed F1 · derivative.exercise_price: Convertible on a 1 for 1 basis. F2 · derivative.exercise_date: The shares attributable to the phantom stock units generally first become distributable upon the January 1 following the date of termination of service pursuant to an earlier election in accordance with the Plan terms. F2 · derivative.expiration_date: The shares attributable to the phantom stock units generally first become distributable upon the January 1 following the date of termination of service pursuant to an earlier election in accordance with the Plan terms. F3 · balance_after: Includes 279.40 previously unreported phantom stock units accrued under the dividend reinvestment feature of the Plan. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 23:21 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 3,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036261 · doc4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,932 F1 · kind: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award. F1 · price: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award. F2 · balance_after: Includes 102 previously unreported restricted stock units that have been credited as dividend equivalents under the deferral feature of the 2003 Plan. Read SEC document |
| February 08, 2019 Filed Feb 8, 2019 23:33 UTC | MACERICH CO MAC · Entity 3712 | GrantPhantom Stock Units · Derivative | 250.07 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008735 · doc4.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,967.95 Underlying: Common Stock · 250.07 shares Expires not disclosed F1 · derivative.exercise_price: Convertible on a 1 for 1 basis. F2 · derivative.exercise_date: The shares attributable to the phantom stock units generally first become distributable upon the January 1 following the date of termination of service pursuant to an earlier election in accordance with the Plan terms. F2 · derivative.expiration_date: The shares attributable to the phantom stock units generally first become distributable upon the January 1 following the date of termination of service pursuant to an earlier election in accordance with the Plan terms. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:43 UTC | Playa Hotels & Resorts N.V. PLYA · Entity 78181 | GrantOrdinary Shares | 10,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000068 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,054 Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 01:38 UTC | MACERICH CO MAC · Entity 3712 | GrantPhantom Stock Units · Derivative | 1,920.84 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001579 · doc4.xml · derivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,717.88 Underlying: Common Stock · 1,920.84 shares Expires not disclosed F1 · derivative.exercise_price: Convertible on a 1 for 1 basis. F2 · derivative.exercise_date: The shares attributable to the phantom stock units generally first become distributable upon the January 1 following the date of termination of service pursuant to an earlier election in accordance with the Plan terms. F2 · derivative.expiration_date: The shares attributable to the phantom stock units generally first become distributable upon the January 1 following the date of termination of service pursuant to an earlier election in accordance with the Plan terms. F3 · balance_after: Includes 21.91 previously unreported phantom stock units accrued under the dividend reinvestment feature of the Plan. Read SEC document |
| December 18, 2018 Filed Dec 21, 2018 01:02 UTC | MACERICH CO MAC · Entity 3712 | PurchaseCommon Stock | 4,500 | $44.63 | $200,826.45 |
DisclosureSEC source: 0001209191-18-063777 · doc4.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Hirsch Family Living Trust Disclosed balance after: 6,020 F1 · price: The purchase price ranged from $44.610 to $44.631. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:56 UTC | MACERICH CO MAC · Entity 3712 | GrantPhantom Stock Units · Derivative | 775.13 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009030 · edgar.xml · derivative · entry 2 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775.13 Underlying: Common Stock · 775.13 shares Expires not disclosed F1 · derivative.exercise_price: Convertible on a 1 for 1 basis. F2 · derivative.exercise_date: The shares attributable to the phantom stock units first become distributable upon the January 1 following the date of termination of board service in a single lump sum pursuant to earlier elections in accordance with the Plan terms. F2 · derivative.expiration_date: The shares attributable to the phantom stock units first become distributable upon the January 1 following the date of termination of board service in a single lump sum pursuant to earlier elections in accordance with the Plan terms. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:56 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009030 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,520 Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 16:23 UTC | Playa Hotels & Resorts N.V. PLYA · Entity 78181 | PurchaseOrdinary Shares | 10,000 | $10.60 | $106,000.00 |
DisclosureSEC source: 0001123292-18-000513 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,324 Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:34 UTC | Playa Hotels & Resorts N.V. PLYA · Entity 78181 | GrantOrdinary Shares | 6,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-18-000063 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,324 Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 16:17 UTC | Playa Hotels & Resorts N.V. PLYA · Entity 78181 | PurchaseOrdinary Shares | 5,000 | $10.42 | $52,100.00 |
DisclosureSEC source: 0001123292-17-001714 · edgar.xml · nonDerivative · entry 2 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,367 F2 · price: This transaction was executed in multiple trades at prices ranging from $10.41 to $10.43; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Playa, or a security holder of Playa. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 16:17 UTC | Playa Hotels & Resorts N.V. PLYA · Entity 78181 | PurchaseOrdinary Shares | 25,000 | $10.54 | $263,500.00 |
DisclosureSEC source: 0001123292-17-001714 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,367 F1 · price: This transaction was executed in multiple trades at prices ranging from $10.52 to $10.55; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Playa, or a security holder of Playa. Read SEC document |
| May 26, 2017 Filed May 31, 2017 17:29 UTC | Playa Hotels & Resorts N.V. PLYA · Entity 78181 | GrantOrdinary Shares | 7,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-17-001061 · edgar.xml · nonDerivative · entry 1 Hirsch Daniel J. · CIK 0001453077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,367 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.